Floatz logo

Eloxatin

Anal Squamous Cell Carcinoma

Columbia UniversityPhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the Anal Squamous Cell Carcinoma cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Columbia University
Phase 2BB
Carboplatin
Fudan University
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB
ETOPOSIDE
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B
Toripalimab
Sun Yat-sen University
Phase 2B

View all 16 →

Same molecule, other indications

Eloxatin is also rated in:

exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
colon adenocarcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →